Globus Medical (GMED) Tops Q3 EPS by 3c

Globus Medical (NYSE: GMED) reported Q3 EPS of $0.57, $0.03 better than the analyst estimate of $0.54. Revenue for the quarter came in at $383.64 million versus the consensus estimate of $286.12 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity